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In acute myocardial infarction, myocardial salvage is
dependent on rapid restoration of blood flow. Phar-
macologic (streptokinase, recombinant tissue-type plas-
minogen activator), mechanical (percutaneous translu-
minal coronary angioplasty, guide wire perforation) or
combined forms of reperfusion therap y can accomplish
this goal, but their effects on infarcted myocardium and
vessel occlusion site have not been compared at necropsy.
The heart of 19 necropsy pat ients who had received var-
ious forms of acute reperfusion therap y was studied:
14 had pharmacologic or combined forms of reperfusion
therapy (13 streptokinase and I tissue-type plasminogen
activator, including 4 with combined balloon angio-
plasty) and 5 had had purely mechanical (balloon an-
gioplasty) reperfusion therapy. Reperfusion was initially
clinically successful in all 19 patients with the average
time from onset of symptoms to reperfusion being 3.7
hours.
Necropsy observations separated the 19 patients into
distinct subgroups based on changes in the myocardium
and infarct-related coronary arteries. Of the 19patients,
The focus of management and treatment of patients with
evolving acute myocardial infarction is currently directed
toward limiting the amount of myocardial necrosis. Non-
surgical attempts to salvage jeopardized myocardium have
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14 (74%) had hemorrhagic myocardial infarction and
they all received pharmacologic or combined forms of
reperfusion therapy. The remaining five patients (26%)
had nonhemorrhagic (anemic) infarction and were treated
with balloon angioplasty therapy alone. Increased lu-
minal cross-sectional area was present in 8 of 9 patients
with acute balloon angioplasty but severe coronary ath-
erosclerotic plaque remained in 9 of 10 patients without
acute balloon angioplasty. Severe hemorrhage sur-
rounded angioplasty sites in all four patients who also
received streptokinase or tissue-type plasminogen acti-
vator. Severe bleeding at the angioplasty site compro-
mised the dilated coronary lumen in one patient. No
patient with angioplasty alone had intraplaque bleeding.
Thus, acute coronary balloon angioplasty reperfusion
therapy alone appears to avoid the potentially adverse
effects of myocardial and intraplaque hemorrhage while
simultaneously increasing luminal cross-sectional area
at the site of acute occlusion.
(J Am Coil Cardiol 1987;9:785-801)
employed methods of rapid restoration of coronary blood
flow using purely pha rmacologic (streptokinase, urokinase,
tissue-type plasminogen activator). purely mechanical (per-
cutaneous transluminal balloon angioplasty, guide wire per-
foration) or combined types of reperfusion therapy. Despite
the widespread use of various forms of reperfusion therapy.
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Table 1. Certain Clinical and Morphologic Observations in 19 Necropsy Patients With Acute Myocardial Infarction Undergoing
Various Types (mechanical, pharmacologic, combination) of Reperfusion Therapy
Thrombolytic therapy With ( + ) or Without ( - ) PTCA
Streptokinase Only
(n = 9)
Clinical data
I. Age (yr) & Sex 46M 51M 55M 58M 60M 63M 66M 66M 66F
2. Location AMI P A A A P A A P A
3. Infarct vessel LC LAD LAD LAD R LAD LAD R LAD
4. Form of reperfusion therapy
a) Mechanical 0 0 0 0 0 0 0 0 0
b) Pharmacologic (dose) (units) IV IC IC IC IC IC IC IV IV
2.7 million 160,000 200,000 250,000 275,000 195,000 175,000 1.5 million 900,000
5. Interval onset symptoms to reperfusion
(hours) 3.5 4.0 3.5 4.5 4.0 3.0 2.5 3.5 <4
6. Initially angiographically successful
reperfusion - h + + + +" + + +
7. Interval reperfusion to death (hours) 72 24 24 16 96 48 12
8. Interval onset of symptoms to death (days) 3.8 3.2 1.2 1.2 0.9 4.1 2. I 3.1 4.0
9. Mode of death PCHF PCHF PCHF PCHF PCHF PCHF PCHF SVF M Rup
Necropsy data
I. Type transmural AMI
a) Anemic 0 0 0 0 0 0 0 0 0
b) Hemorrhagic + + + + + + + +c +
2. Histology of AMI
a) Contraction band necrosis + + + + + + + +c +
b) Coagulation necrosis + + + + + + + + +
c) Interstitial necrosis + + + + + + + 0 +
d) Interstitial extravasated RBC
(0 to 4) 4+ 4+ 4+ 4+ 4+ 4+ 4+ 1+ 4+
I) Massive (grossly visible) + + + + + + + 0 +
2) Focal (microscopic only) 0 0 0 0 0 0 0 + 0
3) Extravasated RBC limited to
necrotic zone + 0 0 + + 0 + + +
3. Histology of infarct coronary artery
a) Residual thrombus + + + + + + + + 0
I) Occlusive + 0 0 0 + + + + 0
b) Underlying atherosclerotic plaque
(% XSA) 51 to 75 >75 >75 >75 >75 >75 >75 >75 >75
c) Intraplaque hemorrhage 0 0 0 0 0 0 0 0 0
d) Intimal-medial "crack" +h 0 0 0 0 0 0 0 0
"Initial reperfusion but subsequent thrombosis; hcoronary angiogram not performed but slight decrease in chest pain initially after streptokinase therapy;
'minute trace of myocardial hemorrhage indicating temporary or partial reperfusion; dunable to significantly open left main artery with infusion of
streptokinase or attempt at guide wire perforation; "focal areas of mild fiber hypereosinophilia; /coronary artery dissection with adventitial hemorrhage;
g initial flap with surrounding thrombus; h streptokinase one day before unsuccessful angioplasty.
A = anterior (anteroseptal); AMI = acute myocardial infarction; CA Rup = coronary artery rupture; F = female; Fo = focal; GWP = guide wire
few necropsy observations have been reported describing
resultant changes in myocardium or infarct-related coronary
arteries (1-14). Thus far, necropsy observations have been
limited to patients receiving either streptokinase (1-10,12,14)
or urokinase (11,13) thrombolytic therapy. This report of
19 necropsy patients with evolving acute myocardial in-
farction compares the status of ventricular myocardium and
infarct-related coronary artery in patients undergoing purely
pharmacologic (streptokinase or tissue-type plasminogen ac-
tivator), purely mechanical (percutaneous transluminal
coronary angioplasty) or combined forms of acute reper-
fusion therapy.
Methods
Clinical and morphologic definitions. Time from onset
ofsymptoms to reperfusion. This was defined as the interval
from the onset of clinical symptoms to angiographic visu-
alization of the distal coronary artery segment in the totally
occluded infarct artery. In three patients, intravenous strep-
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Table 1. (continued)
Thrombolytic Therapy With ( + ) or Without ( - ) PTCA Percutaneous Transluminal Coronary
PTCA + S S + Guide Wire r-TPA + PTCA Angioplasty Only
(n = 3) (n = I) (n = I) (n = 5)
52M 54M 58M 44F 45F 52M 52M 62M 63M 66M
A A A A A A P A A P
LAD LAD LAD LM LAD LAD R LAD LAD R
+ + + GWP + + + + + +
IC IC IC IC IC 0 0 0 0 0
50,000 80,000 70,000 80,000 80 mg
4.0 3.5 4.5 3.5 3.5 3.5 4.0 4.5 4.0 3.0
+" + + +d + + + + + +
44.5 16 12 20.5 44 259.5 2
1.0 2 0.9 I 0.6 I 2 1\ 0.3 1\
PCHF VF PCHF PCHF CA Rup VF VF NC SVF M Rup
0 0 0 0 0 + + + + +
+ + + + + 0 0 0 0 0
+ + + + + '-:0 + + + +Fo +
+ + + + + + + + Fo 0'- +
+ + + + + + Fo +i-'o + Fo 0 +
4+ 4+ 4+ 4+ 4+ 1+ 1/2+ 0 0 1+
+ + + + + 0 0 0 0 0
0 0 0 0 0 + + 0 0 +
+ + + 0 + + + +
+ + + + 0 + + 0 + +
0 0 + 0 0 + + 0 0 +
>75 51 to 75 51 to 75 >75 51 to 75 51-75 51-75 51-75 51-75 51-75"
+ + + 0 + 0 0 0 0 0
+ + + 0 +' + + + + +
perforation; IC = intracoronary; IV intravenous; LAD left anterior descending artery; LC = left circumflex coronary artery; LM left main
artery; M = male; M Rup = myocardial rupture; NC = noncardiac; P = posterior ("inferior, inferoseptal, posteroseptal"): PCHF = progressive
congestive heart failure; PTCA = percutaneous transluminal coronary angioplasty; R = right; r-TPA = recombinant tissue-type plasminogen activator;
S = streptokinase; SVF = sudden unexpected ventricular fibrillation; XSA = cross-sectional area; VF = ventricular fibrillation; + = positive or
present; 0 = negative or absent; - = no data or not applicable.
tokinase therapy was given without initial coronary angio-
graphic monitoring and an estimate of reperfusion time was
assessed by lessening of symptoms and pertinent electro-
cardiographic findings (reperfusion ventricular arrhythmia
and reduction of ST segment elevation) after administration
of streptokinase.
Angiographically successful coronary reperfusion. Ini-
tially successful coronary reperfusion was defined as visu-
alization of the distal coronary artery segment in the totally
occluded infarct artery. In patients without coronary angi-
ography, this determination was not possible.
Progressive congestive heart failure. The mode of death
in 10 patients was progressive signs and symptoms of
congestive heart failure (pulmonary edema) due to under-
lying acute myocardial infarction.
Location ofacute myocardial infarction. The infarct site
was classified anatomically as anterior or posterior. Anterior
infarcts included myocardial necrosis of the anterior left
ventricular free wall with or without associated involvement
of ventricular septum or lateral free wall. Posterior infarcts
included myocardial necrosis of the posterior left ventricular
free wall ("inferior" infarct) with or without associated
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involvement of ventricular septum or lateral free wall. All
infarcts were transmural (defined as involvement of greater
than the inner one-half of the left ventricular wall),
Infarct vessel. The major epicardial coronary artery cor-
responding to the zone of infarction was termed the infarct-
related artery ,
Interstitial extravasated erythrocytes. The presence of
extravasated erythrocytes within the myocardial interstitial
space was classified as massive extravasation (grossly and
microscopically visible) or f ocal extravasation (microscop-
ically visible only). The presence of massively extravasated
erythrocytes producing grossly visible myocardial hemor-
rhage was termed hemorrhagic infar ction . In contrast, focal
areas of interstitial erythrocytes apparent only on micro-
scopic examination did not produce grossly visible myo-
cardial hemorrhage and were classified under anemic in-
farction with interstitial extravasated erythrocytes . The degree
of interstitial extravasated erythrocytes was graded as mild
and focal ( I + ), mild and extensive (2 +), moderate and
extensive (3 + ) or severe and extensive with sheets of packed
erythrocytes (4 + ).
Residual coronary artery thrombus . A grossly or his-
tologically detectable collection of fibrin , platelets and
erythrocytes along the coronary artery wall was defined as
residual thrombus, Thrombus filling the residual coronary
artery lumen was defined as occlusive thrombus,
Patients studied. Between September 1982 and June
1986, the heart from 19necropsy patients who had received
various forms of reperfusion therapy for evolving acute
myocardial infarction was examined. The hearts were ob-
tained from four hospitals in two states. Gross and histologic
examinations were evaluated independently by the local hos-
pital pathologists and all hearts were examined grossly and
histologically by one of us (B.F.W,). Medical records in-
cluding results of cardiac catheterization and coronary an-
giography were reviewed for each patient.
Table I summarizes certain clinical information in the
19necropsy patientsreceiving reperfusion therapy forevolving
acute myocardial infarction. Age at death ranged from 44
to 66 years (average 57), and 16 (85%) of the patients were
men. The acute myocardial infarct was located anteriorly
in 14 patients (74%) and posteriorly in 5 (26%). No patient
had clinical evidence of infarct extension or reinfarction
after reperfusion therapy. The infarct-related artery was the
left anterior descending coronary artery in 13 anterior in-
farcts, the left main coronary artery in I anterior infarct,
and the right (4 infarcts) or left circumflex (I infarct) coro-
nary artery in the remaining 5 posterior infarcts. Of the 19
patients, 16 had an angiographically documented totally
occluded infarct-related coronary artery before onset of
reperfusion therapy. The remaining three patients had in-
travenous streptokinase therapy without preceding coronary
angiography.
Pathologic studies. At least eight histologic sections
stained with hematoxylin-eosin (each myocardial sample
measuring about 2.5 x 1.5 cm) were obtained from the left
ventricle of each heart (Fig. I) : two sections from the central
zone of necrosis, four sections from the transitional zones
of infarcted and noninfarcted muscle and two sections from
noninfarcted, nontransitional zone myocardium. Each sec-
tion was evaluated for contraction band and coagulative
necrosis and interstitial extravasated erythrocytes. The high-
est grade (0 to 4 +) of extravasated interstitial erythrocytes
was recorded. In addition, the infarct-related coronary artery
was cut into serial cross sections and stained with hema-
toxylin-eosin and elastic stains. The amount of luminal cross-
sectional area reduction by atherosclerotic plaque or throm-
bus, or both, was determined by microscopic examination
magnified 25 to 50 times. The accuracy of these determi-
nations was verified by videoplanimetry.
Results
Clinical data (Table 1). The acute reperfusion therapy
included purely pharmacologic therapy (streptokinase in nine
patients), purely mechanical therapy (coronary angioplasty
in five patients) and combined forms of reperfusion therapy
(coronary angioplasty plus streptokinase in three patients.
streptokinase plus guide wire perforation in one patient and
recombinant tissue-type plasminogen activator plus coro-
nary angioplasty in one patient).
Patients who received combined forms of reperfusion
therapy (angioplasty plus lytic agent) had an acute angio-
plasty procedure initially followed within minutes by intra-
coronary streptokinase or tissue-type plasminogen activator.
A subgroup of patients with initial lytic therapy followed
by balloon angioplasty several days later was not available
for comparison. All patients had similar therapy with intra-
venous nitroglycerin and heparin, Of the 19 patients, 14
had thrombolytic therapy with or without associated coro-
nary angioplasty and 5 had coronary angioplasty alone.
The interval from onset of symptoms to clinical or an-
giographic evidence of coronary reperfusion ranged from
2.5 to 4.5 hours (mean 3.7 ± 0.5). This interval in the 14
patients with thrombolytic therapy (with or without angio-
plasty) (2.5 to 4.5 hours, mean 3,7 ± 0.5) was similar to
that in the 5 patients treated with angioplasty alone (3.0 to
4.5 hours, mean 3.8 ± 0.5). The interval from onset
of symptoms to death ranged from 0.3 to II days (mean
2.9 ± 3). This interval was shorter in the patients with
thrombolytic therapy (with or without angioplasty) (0.6 to
4.1 days, mean 2. 1 ± I) than in the patients with angio-
plasty alone (0.3 to II days, mean 5.1 ± 5). The mode of
death was progressive congestive heart failure due to un-
derlying acute myocardial infarction (10 patients), sudden
ventricular fibrillation (unrelated to acute reperfusion ven-
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Figure 1. Transverse section of ventricular myo-
cardium showing eight sites of histologic sectioning
used in the study: A = central zone of necrosis
(two areas); B = transition (borderline) zone from
necrotic to ischemic to normal myocardium (four
areas); C = noninfarcted, nontransition zone myo-
cardium (two areas). A (attopof figure) = anterior;
LV = left ventricular cavity; P = posterior; RV
= right ventricular cavity.
tricular arrhythmias) (5 patients), left ventricular free wall
rupture (2 patients), coronary artery rupture (associated with
balloon angioplasty) (I patient) and noncardiac death (renal
failure) (I patient).
Necropsy data (Table 1). All 19patients had transmural
acute myocardial infarction confirmed histologically: 18pa-
tients with coagulative and contraction band necrosis and I
patient with contraction band necrosis and fiber hypereo-
sinophila. The latter patient died 6 hours after onset of
symptoms of acute myocardial infarction (2 hours after acute
balloon angioplasty reperfusion). Interstitial necrosis (in-
cluding necrosis of vascular channel walls) determined his-
tologically was present in the central necrotic zone in 17
patients; it was extensive in 14 of the 17 patients and focal
in the remaining 3. Residual (occlusive and nonocclusive)
thrombus was found in 16of the 19 infarct-related coronary
arteries; severe underlying atherosclerotic plaque was pres-
ent in each of these infarct-related arteries.
Gross myocardial morphology (Table 1). Of the 19
patients, 14 (74%) had a hemorrhagic myocardial infarct
(Fig. 2 to 4) and 5 (26%) had an anemic infarct (Fig. 5).
Hemorrhagic infarction was present in the heart of all 14
patients who were treated with thrombolytic therapy (strep-
tokinase in 13 [Fig. 2 and 3J and tissue-type plasminogen
activator in 1 [Fig. 4]) irrespective of associated balloon
angioplasty or attempted guide wire perforation of throm-
bus. No morphologic difference was apparent in hemor-
rhagic infarcts associated with selective (intracoronary) or
systemic (intravenous) streptokinase administration. In marked
contrast, all of the five anemic infarcts were present in the
heart of patients who received purely mechanical reperfu-
sion therapy (coronary balloon angioplasty) (Fig. 5).
Among the /4 hearts with hemorrhagic infarction. I heart
had only traces of myocardial hemorrhage suggesting tem-
porary or partial reperfusion, or both (Table 1). During
systemic streptokinase administration, the patient had a tran-
sient decrease in chest pain and ST segment elevation but
subsequent fatal sudden ventricular fibrillation 72 hours later.
At necropsy, the infarct-related right coronary artery was
occluded by severe atherosclerotic plaque and residual
thrombus supporting the myocardial observation of limited
hemorrhagic necrosis from temporary and partial reperfu-
sion. Among patients with streptokinase therapy, hemor-
rhagic infarcts were grossly and histologically similar in the
nine patients who received streptokinase only (Fig. 2), the
three patients with combined streptokinase and balloon an-
gioplasty (Fig. 3) and the one patient with streptokinase and
attempted guide wire perforation of coronary thrombus. The
hemorrhagic infarct in the patient receiving recombinant
tissue-type plasminogen activator was grossly and histolog-
ically similar to the hemorrhagic infarcts observed in the
patients receiving streptokinase therapy (Fig. 4).
Among the /4 patients with hemorrhagic infarction. no
morphologic or histologic difference was apparent in the
amount of hemorrhage observed with respect to the interval
of time from the onset of symptoms to clinical reperfusion
(Table 1). Myocardial infarct hemorrhage in patients with
reperfusion by 3.5 hours or less (range 2.5 to 3.5, mean
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3.3 :t 0.4) was qualitatively similar in extent and severity
to myocardial hemorrhage in patients with reperfusion of
3.6 hours or longer (range 4.0 to 4.5, mean 4.2 :t 0.3).
Myocardial histology. Histologic sections from the cen-
tral infarct zones (Fig. I) showed coagulative necrosis in-
volving myofibers and interstitial vessels. In the 14 hearts
with hemorrhagic infarction, the interstitial space was packed
with extravasated erythrocytes (Fig. 6A,B,C). In contrast,
histologic sections from central infarct zones of three of the
five hearts with anemic infarcts disclosed scattered foci of
erythrocytes (Fig. 6D). Histologic sections from borderline
(transition) zones (Fig. I) showed extravasated erythrocytes
confined to the zone of coagulative necrosis in 10of the 14
hearts with hemorrhagic infarction, whereas in the remain-
ing four hearts, interstitial spaces between histologically
normal-appearing myocytes contained extensive amounts of
extravasated erythrocytes which surrounded vascular chan-
nels whose walls appeared viable (that is, absent wall ne-
crosis) (Fig. 7A and B).
All four patients with extravasated erythrocytes outside
the zone of necrosis received intracoronary streptokinase
thrombolytic therapy. The interval from onset of symptoms
to clinical reperfusion ranged from 3.0 to 4.0 hours (mean
3.5 :t 0.4) and the interval from onset of symptoms to
death ranged from 1.0 to 4.1 days (mean 2.4 ± I). These
values did not signifi cantly differ from those of the re-
maining patients who received streptokinase thrombolytic
therapy (2.5 to 4.5 hours, mean 3.7 :t 0.6; 0.9 to 4.0 days,
mean 2.0 :t I, respectively) (Fig. 2, 3, 6 and 7). Histologic
sections from the borderline (transition) zones in the anemic
infarcts disclosed occasional myocardial contraction bands
but the interstitial spaces were free of erythrocytes. Histo-
logic sections of noninfarcted, nontransition zone myocar-
dium (Fig. I) from all 19 hearts disclosed no extravasated
interstitial erythrocytes.
Residual thrombus in infarct-related coronary artery.
Of the 19 infarct-related coronary arteries, 16 (84%) had
residual thrombus at the site of previous occlusion (Fig. 8
and 9). In 9 (56%) of the 16 arteries, the residual thrombus
was occlusive (Fig. 9); 6 of the arteries were from patients
who had received thrombolytic therapy and 3 were from
patients treated only with angioplasty.
Residual atherosclerotic plaque in infarct-related
coronary artery. The amount of residual atherosclerotic
plaque at the site of previous coronary artery occlusion
depended on the type of acute reperfusion therapy. All 19
infarct arteries were narrowed greater than 50% in cross-
sectional area by atherosclerotic plaque at the site of pre-
vious occlusion (Fig. 8 and 9). In 9 (90%) of the 10 patients
receiving thrombolytic agents alone, the sites of previous
occlusion were narrowed 76 to 100% in cross-sectional area
by atherosclerotic plaque. The remaining patient had the
site of previous occlusion narrowed 51 to 75% in cross-
sectional area. Because of continued pain, this patient was
Figure4. Reperfusion therapy with combined recombinant tissue
plasminogen activator and coronary angioplasty. Transmural,
hemorrhagic myocardial infarction is present in the anterior left
ventricular (LY) free wall. The patient died after coronary artery
rupture. AY = aortic valve; MY = mitral valve.
treated with coronary balloon angioplasty 24 hours after
acute intravenous streptokinase therapy. Of the remaining
nine patients who had coronary angioplasty (with or without
thrombolytic therapy), eight had an infarct artery that was
narrowed 51 to 75% in cross-sectional area by plaque (Fig.
9). The remaining patient had an infarct artery narrowed 76
to 100% in cross-sectional area by plaque (Fig. 8). The
increased luminal cross-sectional area observed at the site
of previous occlusion in the patients treated with balloon
angioplasty was due to intimal-medial "cracks" and "breaks"
in the atherosclerotic plaque.
Site of acute angioplasty. Among the nine patients with
acute balloon angioplasty reperfusion therapy, four also re-
ceived streptokinase (three patients) or tissue-type plasmin-
ogen activator (one patient). A major difference between
the two subgroups of patients undergoing angioplasty was
present at the respective angioplasty sites. External exam-
ination of the infarct artery disclosed adventitial hemorrhage
surrounding the angioplasty site in patients receiving both
angioplasty and a thrombolytic agent, but not in those pa-
tients treated with angioplasty alone (Fig. 8A). In the four
patients with combined angioplasty and thrombolytic ther-
apy. the area of plaque "cracking" also contained intimal
and medial hemorrhage . Bleeding at the angioplasty site
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Figure 6. Comparison of histologic findings in areas of acute
myocardial damage after four types of reperfusion therapy. A,
Streptokinase (Strept) only, B, Streptokinase plus percutaneous
transluminal coronary angioplasty (PTCA); C, tissue-type plas-
minogen activator (TPA) plus coronaryangioplasty: 0, angioplasty
only. In each type of thrombolytic reperfusion (with or without
associated angioplasty), the interstitial space contains massive
amounts of extravasatederythrocytes (hemorrhagic infarction) (ar-
rows), whereas in the purely mechanical form of reperfusion (0) ,
hemorrhagic infarction is absent. Hematoxylin-eosin stains: A,B,
x 40: C, x 10; 0 , x 160; all reduced by 31%.
was severe and compromised the dilated lumen in one pa-
tient (Fig. 88 to E). In contrast, the remaining five infarct
arteries dilated without the additional use of thrombolytic
agents showed intimal-medial "cracks" without associated
hemorrhagic changes (Fig. 9).
Discussion
The purpose of this study was to determine the morpho-
logic and histologic status of ventricular myocardium and
the infarct-related coronary artery in necropsy patients who
had been treated with various types of initially clinically
successful reperfusion therapy for evolving acute myo-
cardial infarction. Results of the morphologicand histologic
observations permit separation of the patients into distinct
subgroups based on changes in the myocardium and infarct
coronary artery.
Myocardium. Gross and histologic observations in the
ventricular myocardium clearly separated the 19 patients
into two subgroups: those patients with and those without
hemorrhagic myocardial infarction . Of the 19 necropsy pa-
tients, 14 (74%) had a hemorrhagic myocardial infarct and
five (26%) had a nonhemorrhagic (grossly anemic) myo-
Figure 7 . Histologic section s near the transition zone of necrotic to viab le myocardium from two patients with strep toki nase thrombolysis . A, Low
power ( X 160 ) view showing interstitial extravasated erythrocy tes Oil/side the zone of central necrosis. Interstit ial hem orrh age is surrounded by
histologically normal -appearing myocytes. A', Higher magni fication ( x 400) of boxed area see n in A. H, Photomicrograph fro m another patient showing
mass ive interst itia l hemorrhage outside the zone of myocardial necrosis . A vasc ular channel within the interstitial space is surrounded by massively
ext ravasated erythrocy tes. H', Higher magnification ( x 400) of boxed area in H shows pote ntial compress ion of vascular channels (arrows) by eryt hrocy tes
packed with in the interstitium. Adjace nt areas of viable myocard ium may be jeopard ized because of increased interst itial pressure and subsequent
dim inished coro nary perfusio n. This may be a mechan ism for infarct expansion in hemorrhagic infarct ion . All reduced by 3 1% .
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Figure8. Gross and histologic changes
in the infarct-related artery (left anterior
descending [LAD]) artery of a patient
receiving combined streptokinase and
coronary angioplasty (PTCA) reperfu-
sion therapy. A, External view of the
left anterior descending artery discloses
severe adventitial hemorrhage sur-
rounding the site of angioplasty. B, C
and D, Transverse coronary sections
through the angioplasty site disclose an
atherosclerotic plaque (AP) "crack" (B)
with severe intimal and medial hemor-
rhage (H). The hemorrhage produces se-
vere coronary luminal narrowing at the
site of previous angioplasty luminal ex-
pansion (C and D). E, Histologic sec-
tion corresponding to the coronary seg-
ment illustrated in D showing severe
medial bleeding (H) (localized dissec-
tion) and atherosclerotic plaque (AP)
"crack." Similar coronary artery plaque
hemorrhage was observed in four pa-
tients with combined angioplasty and
thrombolytic therapy but was absent in
infarct-related arteries of patients treated
with angioplasty alone or streptokinase
alone.
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cardial infarct. Of the 14patients with a hemorrhagic infarct.
reperfusion therapy consisted of administration of selective
( intracoronary) or systemic (intravenous) streptokinase or
the use of selective (intracoronary) recombinant tissue-type
plasminogen activator. Of these 14 patients with throm-
bolytic therapy. four also underwent coronary angioplasty
as part of the acute reperfusion therapy. Factors such as the
use of intracoronary versus intravenous streptokinase in-
fusion, the use of streptokinase versus tissue-type plasmin-
ogen activator (although only one patient with tissue-type
plasminogen activator was studied) or the use of purely lytic
agents versus combined lytic agent plus balloon angioplasty
did not alter the occurrence or appearance of the hemor-
rhagic infarction. In contrast. the remaining five patients
with a grossly anemic ventricular infarct received purely
mechanical reperfusion therapy with percutaneous balloon
angioplasty. Thus. a common denominatorfor the pat ients
with hemorrh agic myocardial infarction app ears to he re-
lated to the lyt ic effects of the pharmacologic reperj usion
agents employed rather than a direct effect or the coronarv
reperfusion (Fig. 10).
Infarct-related artery. Gross and histologic observa-
tions in the infarct-related reperfused coronary artery also
separated the 19 necropsy patients into two distinct groups:
those patients treated with and those without coronary an-
gioplasty. Of the 19 necropsy patients. 9 (47%) underwent
acute balloon angioplasty and had morphologic evidence of
plaque " cracks," "fractures" and medial dissection that
appeared to increase the coronary luminal cross-sectional
area in eight of the nine arteries dilated. Of the nine dilation
sites, eight had a reduction of 51 to 75% in luminal cross-
sectional area and one a 76 to 100% narrowing of cross-
Figure 9. Composite of 5 mrnhistologic cross sections of infarct-
related coronary artery (left anterior descending) from a patient
with acute reperfusion using coronary balloon angioplasty only.
Atherosclerotic plaque "c racks" (arrows) expand the coronary
lumen (sections 1,4 and 5). Occlusive thrombus (T) is present in
segments 2 and 3. Note the absence of intimal. medial and ad-
ventitial coronary artery wall hemorrhage in marked contrast to
Figure 8 from a patient who underwent combined angioplasty and
streptokinase therapy.
sectional area by atherosclerotic plaque. In contrast, 9 of
the 10 remaining infarct coronary arteries from patients with
thrombolytic therapy without balloon angioplasty had no
morphologic evidence of plaque disruption or localized me-
dial dissection and the nine sites of previous occlusion were
narrowed 76 to 100% in cross-sectional area by atheroscle-
rotic plaque. Thus. in patients treated with acute angioplasty
reperfusion therapy . the sites of previous total occlusion
had less luminal cross-sectional area reduction by residual
atherosclero tic plaque than did the sites of previous total
occlusion in pati ents treated with thrombolytic agents .
Intraplaque hemorrhage in the infarct-related artery.
The nine patients receiving acute angioplasty reperfusion
therapy also can be separated into two distinct subgroups:
those patients treated with angioplasty alone and those treated
with angiop lasty and thrombolytic agents, In the fi ve pa-
tients treated with angioplasty alone. the site of angioplasty
had plaque "fractures" and "cracks" without intimal or
medial hemorrhage. In contrast, in the four patients treated
with angioplasty plus thrombolytic therapy. the site of an-
gioplasty had plaque "fractures" and " cracks" with hem-
orrhage involving the intimal, medial and adventitial layers
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L2J(M,croscop,c only) (Grossly hemorrhagic) \.-,Jnecrot'c lone ropsy data (1-14), 100 patients have been described in case
reports or as part of larger series. Of these 100 patients, 67
receivedstreptokinase alone, 3 I urokinasealone and 2 strep-
tokinase plus percutaneous transluminal angioplasty. Spe-
cific information on the two patients with combined phar-
macologic and mechanical therapy was not provided (5,6) .
In nine studies (93 patients) (1-3 ,6, 10-13), informationwas
provided on the status of the myocardium. Hemorrhagic
infarction was described in 43 (46%) of these 93 patients.
Explanation for the absence of hemorrhage in the remaining
hearts was not provided. Fujiwara et al. (13) studied 30
necropsy patients after selective intracoronary thrombolysis
with urokinase. Three stages of infarction were described
based on the interval of time (hours) after thrombolytic
therapy. Hearts of patients in stage II (9 hours to I I days
after thrombolytic therapy) had hemorrhagic infarction (15
of 18 patients). These authors concluded that myocardial
hemorrhage increases gradually after acute thrombolytic
therapy, becoming moderately or markedly diffuse after 4
hours. They speculated that hemorrhagic infarction is due
to the combined effects of reperfusion and large doses of
urokinase. Mathey et al. (6) described transmural, hemor-
rhagic myocardial infarction after intracoronary streptoki-
nase in six patients who died I to 18 days after thrombolytic
therapy. They suggested that sudden reperfusion after 3 to
4 hours of coronary artery occlusion was a major deter-
minant in the development of myocardial hemorrhage and
the hemorrhage probably was not the consequence of strep-
tokinase use as such. Eleven reports ( I-4,6-10,12) provide
some information on the status of the infarct-related coro-
nary artery: 29 patients had residual coronary thrombus and
47 patients had variousdegrees of underlyingatherosclerotic
plaque.
Hemorrhagic myocardial infarction. Hemorrhagic
myocardial infarction as defined earlier consists of grossly
visible myocardial blood that histologically is composed of
massive sheets or pools of interstitial erythrocytes. Focal
areas of scattered interstitial erythrocytes within an area of
myocardial necrosis detected only histologically do not ap-
pear to produce the grossly visible hemorrhagic infarct.
Hemorrhagic infarcts frequently coincide with reperfusion
efforts during an evolving acute myocardial infarction
(1-3,6,8,10-13) or during aortocoronary bypass grafting
(33,34), whereas myocardial hemorrhage in acute myo-
cardial infarction without intervening thrombolysis or re-
vascularization therapy is distinctly unusual. In a study (35)
of 119 necropsy patients with fatal acute myocardial in-
farction without the preceding interventions, 3 (2%) had
hemorrhagic infarction. In one of these three patients, over-
whelming sepsis with disseminated intravascular coagula-
tion developed surrounding the acute infarct during repair
of an abdominal aortic aneurysm. The coagulation abnor-
mality may have provided a "natural" thrombolytic state
similar to the pharmacologically induced thrombolytic state
IC) Streptokinase + PTCA
Streptokinase + guidewire
piercing
4'\II \ \. ) I
t :~~~::~~::__.:~~=~~/
(0) TPA + PTCA
(Probably TPA alone)
(B) PTCA alone
(A) Streptokinase alone
d~· · · · · · · ·.. . ' . ' . , " ." . .. .:.. .... " ./ /1 ""·, .:-:/ / t \ ) . \1 1/ \ \ I jI ... ". /' I! '..._-----.) '-.- )
........._---------.._----/
of the coronary artery. In one patient, the hemorrhage was
so extensive that it narrowed the coronary lumen at the
angioplasty site. In the 10 patients receiving streptokinase
therapy alone, intraplaque hemorrhage was absent. Thus.
the use of combined angioplasty and thrombolytic agents in
acute reperfusion therapy may produce localized bleeding
at the angioplasty site and the bleeding may produce ad-
ditional coronary luminal narrowing .
Previous studies. Despite the widespread clinical use
of various forms of acute reperfusion therapy during evolv-
ing acute myocardial infarction, cardiac necropsy obser-
vations are limited (1-14) . Several studies (15- 32) report
deaths or causes of death in patients with reperfusiontherapy
but do not provide necropsy data. In 14 reports with nee-
(EI No thrombolysis therapy
r 'Anemic Infarct")
(Thrombolysis therapy
without raperfusion)
Figure 10. Diagram summarizing myocardial interstitial hernor-
rhage in the present study in evolving acute myocardial infarction
after various forms of reperfusion therapy. Massive interstitial
hemorrhage (hemorrhagic infarct) was observed in patients with
reperfusion using streptokinase alone or incombination with coro-
nary angioplasty (PTCA), and in patients with reperfusion using
tissue plasminogen activator (TPA) with angioplasty. Hemorrhagic
infarction was absent in patients with angioplastyalone or in myo-
cardial infarction without acute intervention or without reperfu-
sion. Interstitial hemorrhage was not limited to the zone of ne-
crosis. RBCs = red blood cells.
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of reperfusion therapy, Reasons for the other two hemor-
rhagic infarcts are unknown. Mathey et al. (6) found hem-
orrhagic infarction in none of 200 necropsy patients with
fatal acute myocardial infarction without interventional ther-
apy, Of 60 necropsy patients with acute myocardial infarc-
tion without thrombolytic therapy studied by Fujiwara et al.
( 13), 2 (3%) had " moderate diffuse hemorrhage" (hem-
orrhagic infarction).
To our knowledge, only two patients have been described
in whom the clinical diagnosis of hemorrhagic infarction
was made after acute thrombolytic therapy (11 ,36). Little
and Rogers (36) reported angiographic evidence of intra-
myocardial contrast pooling (representing interstitial extra-
vasation of erythrocytes) after successful streptokinase ther-
apy. The patient's condition subsequently deteriorated with
infarct extension. Necropsy documentation of hemorrhagic
infarction was not provided. Yasuno et al. (II) reported on
an 83 year old man with angiographic findings suggestive
of intramyocardial hemorrhage after urokinase treatment.
At necropsy, marked transmural hemorrhagic necrosis was
observed in the corresponding area. Yasuno et al. ( 11) sug-
gested stopping thrombolytic agent administration if angio-
graphic evidence of hemorrhagic infarction is observed.
Debate continues as to whether the presence of hemor-
rhage within zones of necrosis delays (6) or accelerates (37)
healing of infarcted myocardium or whether it expands or
accelerates myocardial necrosis (38). Mathey et al. (6) de-
scribed a patient with two infarcts of equal age in whom
one infarct-related artery was reperfused and the other not;
at necropsy, the reperfused artery was associated with a
hemorrhagic infarct and the nonreperfused artery with an
anemic infarct. Distinct histologic differences were noted
between the hemorrhagic and anemic infarcts in terms of
removal of necrotic tissue and replacement by connective
tissue. The hemorrhagic infarct had no evidence of repair
after 18 days, whereas the anemic infarct showed typical
resorption and repair by granulation tissue. This difference
indicated a marked delay in the usual infarct healing process
in the hemorrhagic infarct (6).
Experimental results and clinical differences. Exper-
imental studies in various animals (rats, dogs. pigs) have
been performed to define potential benefits and hazards of
acute myocardial reperfusion. Results of these studies have
been divergent in areas of hemorrhagic infarction, infarct
size reduction or expansion, wall motion changes and altered
survival. Some investigators (37,39- 47) found hemorrhagic
infarction in experimental animals confined to areas of ne-
crosis sparing the subepicardial zone (that is. "subendo-
cardial infarction") and found no evidence of infarct ex-
pansion. Other investigators (38,48- 50) suggested that the
myocardial hemorrhage is not strictly confined to the ne-
crotic zone and that infarct expansion may occur with in-
terstitial hemorrhage. The application of experimental re-
perfusion studies to humans has its limitations with regard
to the animal model used, the nature of coronary artery
occlusion (coronary ligation versus occlusion by atheros-
clerotic plaque and thrombus), the presence or absence of
collateral circulation and the rate of the occlusion process
(slow versus fast). As a consequence of these limitations,
at least two major differences exist between hemorrhagic
myocardial infarcts observed in necropsy patients and in
those observed in experimental animals. First, in patients
the hemorrhagic infarction is transmural and not suben-
docardial as has been described in experimental models (51).
Second. exrension of the hemorrhage into areas of nonin-
[arc ted myocardium has been observed in previously re-
ported necropsy patients (13) as well as in our present study
and may not be confined to the central necrotic zone as has
been described in most experimental models (40,43,45,51)
(Fig. 10).
Clinical-pathologic correlation of the effects of myo-
cardial reperfusion. Significant improvement in left ven-
tricular function after acute coronary reperfusion with strep-
tokinase was not observed in several controlled trials of
intracoronary or intravenous streptokinase therapy
(14, 17. 19,21,52). Only one controlled study (18) using
intracoronary streptokinase in acute myocardial infarcion
showed improvement in serially assessed left ventricular
ejection fraction. In contrast, a recently controlled trial (53)
comparing intracoronary streptokinase and coronary angio-
plasty during evolving acute myocardial infarction showed
that left ventricular ejection fraction significantly improved
during serial testing in the angioplasty group but not in the
streptokinase-treated group. In addition. these authors (53)
noted that residual luminal stenosis in the infarct-related
artery was significantlydecreased angiographically after an-
gioplasty as compared with after streptokinase therapy.
O'Neill et al. (53) suggested that acute angioplasty is sig-
nificantly more effective than streptokinase infusion in al-
leviating the underlying coronary stenosis and that this factor
may result in more effective preservation of left ventricular
function after acute reperfusion therapy.
The morphologic and histologic findings in the infarct-
related coronary artery in our study support these angio-
graphic observations of increased luminal cross-sectional
area after angioplasty reperfusion compared with throm-
bolytic reperfusion therapy. The striking difference between
hemorrhagic infarcts present in our thrombolytic group com-
pared with the anemic infarcts in our pure angioplasty group
suggests that myocardial hemorrhage also may be a factor
in the lack of clinical improvement in left ventricular func-
tion in the streptokinase-treated patients. However, addi-
tional factors such as the time interval between onset of
myocardial infarction and clinical reperfusion, the presence
of collateral circulation and the altered contractility of non-
infarcted myocardium in the acute and follow-up state may
contribute to the lack of improvement in ejection fraction
after thrombolytic therapy.
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